Pharvaris N.V. - 54 Year Dividend History | PHVS
Historical dividend payout and yield for Pharvaris N.V. (PHVS) since 1971. The current TTM dividend payout for Pharvaris N.V. (PHVS) as of February 21, 2025 is $0.00. The current dividend yield for Pharvaris N.V. as of February 21, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.862B |
$0.000B |
|
Pharvaris N.V. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative therapies, including novel, small molecule bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema and other bradykinin-B2-receptor-mediated indications. Pharvaris N.V. is based in ZUG, Switzerland.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
